Bovine Respiratory Disease Treatment Market Share, Size, Forecast and Trends by 2021
©
The Global Bovine Respiratory Disease Treatment Market has been estimated at USD 24.5 million in 2016 and is projected to reach USD 67.31 million by 2021, at a CAGR of 22.4% during the forecast period from 2016 to 2021. The threat of bovine respiratory disease (BRD) has an important effect on the value of cattle in the marketplace. Bovine Respiratory Disease is the most popular and costly disease affecting the beef cattle industry. The disease which affects both lower and upper respiratory tract is referred as BRD.
BRD is a common term for respiratory disease in cattle caused by Variety of factors. A major cause of economic losses, BRD affects the lower respiratory tract / lungs (pneumonia) or upper respiratory tract (rhinitis, tracheid’s, bronchitis).
Full report at: http://www.marketdataforecast.com/market-reports/global-bovine-respiratory-disease-treatment-market-908/
Key factor responsible for the disease is stress. Early detection is touted as an important key to treatment success. Bovine respiratory disease (BRD) can be a costly expense for cattle producers. However, it can be avoided by making the use of vaccines.
The global Bovine Respiratory Disease Treatment Market has been segmented on the basis of type of treatment into anti-infectious agents, anti-Parasiticides, bronchodilators, oral rehydration fluids, non-steroidal anti-inflammatories, and mucolytic. Anti-infectious can be further sub-segmented into antibiotics and sulfas. Antibiotics and anti-inflammatory drugs are now being used for combination treatment and expected to improve the success rate of the treatment.
Based on geography, the market has been segmented into North America, Europe, Asia-Pacific, Latin America and Middle-East and Africa. North America leads the market due to greater occurrence of bovine respiratory disease. In the Asia Pacific region, China and India have greater cattle adoption and are expected to grow fast.
Request sample: http://www.marketdataforecast.com/market-reports/global-bovine-respiratory-disease-treatment-market-908/request-sample
The major companies dominating this market by their products and services are Zoetis Inc., Merck & Co. Inc., Bayer Corporation, Eli Lilly & Co., Merial S.A.S, Boehringer Ingelheim Vetmedica, Novartis Animal Health, Vibrac S.A, Ceva Sante Animale and Vétoquinol S.A.
About Market Data Forecast:
The publisher of this report is Market Data Forecast whose forte lies in Market research and Business Intelligence. Handling both individual and corporate clients across multiple business domains they offer syndicated/customized research to suit the client’s research objective. Their research reports section offers a wide variety of market studies ranging from all-encompassing comprehensive market studies to product specific niche markets covering North America among other regions of the global market as well. For more info kindly visit, www.marketdataforecast.com
Contact:
Abhishek Shukla
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Mail: abhishek@marketdataforecast.com
Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases
BRD is a common term for respiratory disease in cattle caused by Variety of factors. A major cause of economic losses, BRD affects the lower respiratory tract / lungs (pneumonia) or upper respiratory tract (rhinitis, tracheid’s, bronchitis).
Full report at: http://www.marketdataforecast.com/market-reports/global-bovine-respiratory-disease-treatment-market-908/
Key factor responsible for the disease is stress. Early detection is touted as an important key to treatment success. Bovine respiratory disease (BRD) can be a costly expense for cattle producers. However, it can be avoided by making the use of vaccines.
The global Bovine Respiratory Disease Treatment Market has been segmented on the basis of type of treatment into anti-infectious agents, anti-Parasiticides, bronchodilators, oral rehydration fluids, non-steroidal anti-inflammatories, and mucolytic. Anti-infectious can be further sub-segmented into antibiotics and sulfas. Antibiotics and anti-inflammatory drugs are now being used for combination treatment and expected to improve the success rate of the treatment.
Based on geography, the market has been segmented into North America, Europe, Asia-Pacific, Latin America and Middle-East and Africa. North America leads the market due to greater occurrence of bovine respiratory disease. In the Asia Pacific region, China and India have greater cattle adoption and are expected to grow fast.
Request sample: http://www.marketdataforecast.com/market-reports/global-bovine-respiratory-disease-treatment-market-908/request-sample
The major companies dominating this market by their products and services are Zoetis Inc., Merck & Co. Inc., Bayer Corporation, Eli Lilly & Co., Merial S.A.S, Boehringer Ingelheim Vetmedica, Novartis Animal Health, Vibrac S.A, Ceva Sante Animale and Vétoquinol S.A.
About Market Data Forecast:
The publisher of this report is Market Data Forecast whose forte lies in Market research and Business Intelligence. Handling both individual and corporate clients across multiple business domains they offer syndicated/customized research to suit the client’s research objective. Their research reports section offers a wide variety of market studies ranging from all-encompassing comprehensive market studies to product specific niche markets covering North America among other regions of the global market as well. For more info kindly visit, www.marketdataforecast.com
Contact:
Abhishek Shukla
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Mail: abhishek@marketdataforecast.com
Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases